Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells, covering 2025-10-01 to 2025-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over) [Phase 3]